Recovery Management Services Webinars
FEBRUARY 19, 2019 / TUESDAY / @ 2:00 PM EST – “FREQUENTLY ASKED RECOVERY MONITORING QUESTIONS” Presented By: James L. Ferguson, DO, FASAM, Medical Director, Recovery Management Services
What are the most troublesome issues facing recovery monitoring programs? How do these issues impact your participants recovery? The importance of staying abreast of evolving drug screening trends is paramount to establishing a solid recovery monitoring program. Please join FSSolutions as James L. Ferguson, DO, DFASAM, MRO, Medical Director, Recovery Management Services addresses the most commonly asked questions and challenging issues facing all recovery monitoring programs. Dr. Ferguson will discuss the questions and concerns he hears most frequently, as well as provide best practices and strategies for dealing with problems as they arise.
“MONITORING PROGRAM SPECIMEN SELECTION, EVALUATION AND ISSUES” Presented By: James L. Ferguson, DO, FASAM, Medical Director, Recovery Management Services
This webinar will include a discussion about specimen concentration concerns, dilute and low creatinine specimens, follow-up testing protocols and recommendations on these issues.
FEBRUARY 12, 2019 / TUESDAY / SESSION 1: @11:00 AM EST / SESSION 2: @2:00 PM EST – “DRUG TESTING TRIVIA”, Presented by: Regina Doural, CSAPA, General Manager, Compliance Services
How much do you know about drug testing? Whether you are new to drug testing or a veteran in the industry this webinar is for you. Join us to learn some new facts about drugs and your drug testing program. Please join FSSolutions as Regina Doural, CSAPA, General Manager, Compliance Services addresses the most commonly asked questions, some well known facts and some lesser known facts on drug testing.
Some Topics to be Covered:
- Random Testing
- Drug Panels
- Positivity Rates
FEBRUARY 27, 2019 / WEDNESDAY / @ 2:00 PM EST – “ASK THE MRO”, Presented by: Randy Barnett, D.O. Chief MRO
What are the most difficult issues facing drug and alcohol testing programs? How do these issues impact the safety and security of your workforce? The importance of staying abreast of evolving drug & alcohol screening trends is paramount to establishing a solid compliance program. Dr. Barnett will discuss the questions and concerns he hears most frequently, as well as provide best practices and strategies for dealing with problems as they arise.
We will review and answer the following questions, and more during this webinar.
- I haven’t received a result yet, what is causing the delay?
- My collection site has closed, what should I do?
- The MRO contacted me to send my donor back for another test, Why?
- Should I have a random selection each month?
- What do I do with this negative dilute result?
MARCH 13, 2019 / WEDNESDAY / SESSION 1 @ 11:00 AM EST / SESSION 2 @ 2:00 PM EST – “MAKE YOUR DRUG TESTING PROGRAM BETTER – TIPS & TOOLS TO USE”, Presented by: Regina Doural, CSAPA, General Manager, Compliance Services
Whether you are new to drug testing or a veteran in the industry this webinar is for you. Join us to learn some new ways to improve your drug testing program.
Please join FSSolutions as Regina Doural, CSAPA, General Manager, Compliance Services
addresses the tools available to the Designated Employer Representative (DER). The discussion will include some new tools available to the DER and new features available to others that will make your program management easier.
Some Topics to be Covered:
• Electronic Chain of Custody Forms
• Tracking Results
• Improve Turn Around Times
• Sample Reports
MARCH 28, 2019 / THURSDAY / SESSION 1 @ 11:00 AM / SESSION 2 @ 2:00 PM EST – “CBD OIL – A DISCUSSION WITH THE MRO”, Presented by: Randy Barnett, DO, Chief MRO
Cannabidiol (CBD) is one of at least 113 compounds found in cannabis and it has gained popularity in recent years for its perceived health benefits.
How much do you know about CBD Oil? Our discussion will include CBD products available in the US, research studies involving CBD Oil and the legality of using it. Join us to learn the facts about CBD Oil and your drug testing program.
Some Topics to be Covered:
• Available CBD Products
• Research Studies
• FSS policy on reporting THC positive results
Please join FSSolutions as
Dr. Randy Barnett, FSSolutions’ Chief Medical Review Officer (MRO) discusses this popular drug trend and answers your questions.
“BACKGROUND SCREENING SERVICES – MAKING COMPLIANCE EASY” Presented by MARC BOURNE, CCIP, General Manager, Background Screening Services, NAPBS/FCRA Certified
During this webinar, we will highlight our background screening platform with an emphasis on FCRA compliance. As FCRA compliance becomes increasingly important, our system has multiple built-in ways that help our clients maintain compliance, including the delivery and storage of Disclosure and Authorization forms and State specific releases, assisting with the Adverse Action process, and certifying that each background check is submitted for FCRA purposes.
JUNE 6, 2019 / THURSDAY / @ 2:00 PM EST – “UNDER THE INFLUENCE OR IMPAIRED: WHAT ARE THE DIFFERENT TESTING OPTIONS TO CONSIDER” Presented by: Brian Feeley, Director of Sales for OraSure Technologies, Substance Abuse Testing Division
During this webinar, we will discuss the difference between under the influence and impairment as it relates to marijuana issues. Is oral fluid drug testing the best testing methodology to use? We will provide a comparison of oral fluids vs. other testing methodologies, including hair and urine testing. Some scenarios will be presented to demonstrate the best testing method to utilize.
Brian P Feeley,
Director of Sales, Substance Abuse Testing Division
Brian has over 35 years experience in the substance abuse testing industry working in technical, business development, sales and marketing capacities. He is named as an inventor on four patents and has numerous publications across three different scientific disciplines and market areas.
Brian has been at OraSure Technologies for the past 22 years where he has focused on the launch of oral fluid drugs of abuse, alcohol and nicotine testing products. Brian and his team focus on educating and training national laboratory partners, TPAs and end users on the benefits of oral fluid testing to enhance substance abuse screening programs
JULY 30, 2019 / TUESDAY / @ 2:00 PM EST – “FMCSA COMMERCIAL DRIVER’S LICENSE DRUG & ALCOHOL CLEARINGHOUSE” Presented by SHAWN O’NEIL, CSAPA, Executive Vice President, Account Management & Chief Compliance Officer
FMCSA’s final rule published in December 2016 establishes the Commercial Driver’s License Drug & Alcohol Clearinghouse. Compliance with these regulations begins in January 2020. During this webinar we will provide an overview of the regulations and discuss who must access it and when it must be accessed.
The webinar will include these items and more:
• Questions submitted to FMCSA & their responses
• Driver’s responsibilities
• Different types of queries available
• How FSSolutions can assist you
• Employer’s responsibilities
• Required changes to the donor ID used for drug test and alcohol test.
Shawn O’Neil, CSAPA, Executive Vice President, Account Management & Chief Compliance Officer
Shawn O’Neil joined FSSolutions in 2012 as one of the founders of FSSolutions’ Occupational Health Division, with over twenty years of health insurance, transportation regulatory and occupational health experience. As Operational Leader of this business unit, he focused on process creation, employee development and service delivery in a heavily regulated industry.
From 1998-2012, Mr. O’Neil worked for Schneider National, one of North America’s largest providers of truckload, intermodal and logistics services. His experience includes safety, driver recruiting, training, data analysis, DOT & OSHA compliance and reporting, and process design to deliver more effective client solutions.
As Executive Vice President, Client Services and Account Management, & Chief Operations Officer, Mr. O’Neil oversees the implementation and administration of all operating strategies impacting client satisfaction and regulatory compliance.
See All Resources